ORIGINAL ARTICLE
Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study
1 Bruce Lefroy Centre, MCRI, Department of Paediatrics, University of Melbourne, Victoria, Australia
2 Willink Biochemical Genetics Unit, Royal Manchester Childrens Hospital, UK
Correspondence to:
Correspondence to:
Associate Professor M B Delatycki
Bruce Lefroy Centre for Genetic Health Research, 10th floor, Royal Childrens Hospital, Flemington Road Parkville, 3052, Victoria, Australia; martin.delatycki{at}ghsv.org.au
Aims: To determine the incidence, manifestations, and best management of sleep disturbance in Sanfilippo syndrome (mucopolysaccharidosis (MPS) type III).
Methods: Families were ascertained through the MPS societies of Australasia, the UK, and the USA. Questionnaires were sent by mail and were answered anonymously. Identical questions regarding sleep disturbance were asked about unaffected siblings to provide control data. Sleep disturbance was quantified by a total sleep disturbance score.
Results: A total of 141 responses were received; 91.5% of children with Sanfilippo syndrome had sleep disturbance and this was significantly higher than for their unaffected sibs; 77.5% of parents had used medication for this problem, with melatonin and antihistamines being most commonly used. Melatonin and benzodiazepines were reported as the most efficacious. Many different environmental modifications had been employed for this problem and some parents reported success with behavioural therapies.
Conclusions: Sleep disturbance is common, severe, and difficult to manage in Sanfilippo syndrome. Based on the parental responses and its safety profile, melatonin is the first line drug that should be tried. Behavioural therapy should be tried in all with Sanfilippo syndrome and sleep disturbance.
Abbreviations: MPS, mucopolysaccharide; TSD, total sleep disturbance
Keywords: mucopolysaccharidosis; melatonin; behavioural therapy; environmental modification
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Jansen, A. C. M., Cao, H., Kaplan, P., Silver, K., Leonard, G., De Meirleir, L., Lissens, W., Liebaers, I., Veilleux, M., Andermann, F., Hegele, R. A., Andermann, E.
(2007). Sanfilippo Syndrome Type D: Natural History and Identification of 3 Novel Mutations in the GNS Gene. Arch Neurol
64: 1629-1634
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



